The Baker Tilly team understands the ongoing needs and challenges of life sciences companies and offers solutions to address your financial, business, and operational issues.
The issues faced by life sciences companies – including market access and commercialization, international expansion, ongoing funding requirements, an extended FDA approval process, and health economic value analysis – mean you need advisors who have the expertise and industry-specific experience to help you address these matters effectively. In this era of healthcare reform, where defining and messaging your value proposition and facilitating successful market access are keys to revenue generation, life sciences companies are challenged to continually innovate and meet changing customer needs.
Our life sciences team has worked with medical device, biotechnology, pharmaceutical, and medical technology companies to navigate these challenges. We provide you with actionable ideas and solutions, including peer-reviewed health economic studies, drawn from our work with hundreds of life sciences companies.
We work with both privately held and public companies through all stages of the life sciences life cycle – from launch to growth to maturity. If you want a business partner that understands your industry, gets to know your business intimately, and offers profitable solutions while minimizing risk, connect with us.